关注极重度孤独症:临床分类学效度与难治性症状管理

薛洋, 贾飞勇

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (8) : 909-915.

PDF(685 KB)
HTML
PDF(685 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (8) : 909-915. DOI: 10.7499/j.issn.1008-8830.2604056
专家述评

关注极重度孤独症:临床分类学效度与难治性症状管理

作者信息 +

Focusing on profound autism: validity of clinical taxonomy and management of treatment-resistant symptoms

Author information +
文章历史 +

摘要

孤独症谱系障碍依照《精神障碍诊断与统计手册》第5版“广谱系化”的诊断使人们容易忽视病情严重患者的特殊医疗需求。为此,2021年孤独症未来照护与临床研究柳叶刀委员会提出“极重度孤独症”概念,特指年龄在8岁及以上、存在重度智力障碍(智商<50)和/或极少甚至完全缺乏语言表达能力,且需要全天候(24 h)照护的孤独症谱系障碍个体。这些患者常合并隐匿性躯体疾病与致死性自伤、紧张症等难治性精神异常,传统阶梯干预策略常难以奏效。该文系统梳理了极重度孤独症的概念界定与临床表型,强调干预重心应转向严重共患病管理与替代沟通构建,并探讨了改良电休克疗法在难治性危重症中的挽救性应用,旨在为极重度孤独症的多学科诊疗及全生命周期支持体系的建设提供循证依据。

Abstract

The broad-spectrum diagnostic framework for autism spectrum disorder (ASD) in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.) tends to obscure the specific medical and support needs of individuals with severe impairments. In response, the Lancet Commission on the future of care and clinical research in autism proposed the concept of "profound autism" in 2021, referring to individuals with ASD who are aged 8 years or older, have severe intellectual disabilities (IQ < 50) and/or minimal or completely absent verbal communication abilities, and require round-the-clock (24-hour) care. Patients with profound autism often present with occult somatic comorbidities and treatment-resistant psychiatric abnormalities, including life-threatening self-injurious behavior and catatonia, which frequently render traditional stepped-care interventions ineffective. This review systematically summarizes the conceptual definition and clinical phenotypes of profound autism and emphasizes the need to shift the intervention focus toward managing serious comorbidities and establishing augmentative and alternative communication systems. Additionally, the potential application of modified electroconvulsive therapy as a salvage treatment for refractory and life-threatening symptoms is discussed. The aim is to provide evidence-based guidance for multidisciplinary management and the construction of comprehensive lifespan support systems for individuals with profound autism.

关键词

极重度孤独症 / 阶梯式管理 / 电休克疗法 / 儿童

Key words

Profound autism / Stepped-care management / Electroconvulsive therapy / Child

引用本文

导出引用
薛洋, 贾飞勇. 关注极重度孤独症:临床分类学效度与难治性症状管理[J]. 中国当代儿科杂志. 2026, 28(8): 909-915 https://doi.org/10.7499/j.issn.1008-8830.2604056
Yang XUE, Fei-Yong JIA. Focusing on profound autism: validity of clinical taxonomy and management of treatment-resistant symptoms[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(8): 909-915 https://doi.org/10.7499/j.issn.1008-8830.2604056

参考文献

[1]
Wang Y, Lv R, Jiang Z, et al. Autism spectrum disorder across the lifespan: dynamic symptom trajectories and multidimensional support framework[J]. Mol Psychiatry, 2026. Epub ahead of print.DOI: 10.1038/s41380-026-03542-2 .
[2]
Rosen NE, Lord C, Volkmar FR. The diagnosis of autism: from Kanner to DSM-III to DSM-5 and beyond[J]. J Autism Dev Disord, 2021, 51(12): 4253-4270. PMCID: PMC8531066. DOI: 10.1007/s10803-021-04904-1 .
[3]
Kamp-Becker I. Autism spectrum disorder in ICD-11: a critical reflection of its possible impact on clinical practice and research[J]. Mol Psychiatry, 2024, 29(3): 633-638. PMCID: PMC11153155. DOI: 10.1038/s41380-023-02354-y .
[4]
Russell LA, Tinker SC, Shaw KA, et al. Prevalence of autism spectrum disorder severity levels from the fifth edition of the Diagnostic and Statistical Manual (DSM-5) in the Autism and Developmental Disabilities Monitoring Network[J]. J Autism Dev Disord, 2026. Epub ahead of print. DOI: 10.1007/s10803-026-07292-6 .
[5]
Lord C, Charman T, Havdahl A, et al. The Lancet Commission on the future of care and clinical research in autism[J]. Lancet, 2022, 399(10321): 271-334. DOI: 10.1016/S0140-6736(21)01541-5 .
[6]
Wachtel LE, Escher J, Halladay A, et al. Profound autism: an imperative diagnosis[J]. Pediatr Clin North Am, 2024, 71(2): 301-313. DOI: 10.1016/j.pcl.2023.12.005 .
[7]
Hughes MM, Shaw KA, DiRienzo M, et al. The prevalence and characteristics of children with profound autism, 15 sites, United States, 2000-2016[J]. Public Health Rep, 2023, 138(6): 971-980. PMCID: PMC10576490. DOI: 10.1177/00333549231163551 .
[8]
Clarke EB, Mccauley JB, Lutz A, et al. Understanding profound autism: implications for stigma and supports[J]. Front Psychiatry, 2024, 15: 1287096. PMCID: PMC10839016. DOI: 10.3389/fpsyt.2024.1287096 .
[9]
Kapp SK. Profound concerns about "profound autism": dangers of severity scales and functioning labels for support needs[J]. Educ Sci, 2023, 13(2): 106. DOI: 10.3390/educsci13020106 .
[10]
Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: a systematic review update[J]. Autism Res, 2022, 15(5): 778-790. PMCID: PMC9310578. DOI: 10.1002/aur.2696 .
[11]
Kentrou V, Livingston LA, Grove R, et al. Perceived misdiagnosis of psychiatric conditions in autistic adults[J]. EClinicalMedicine, 2024, 71: 102586. PMCID: PMC11001629. DOI: 10.1016/j.eclinm.2024.102586 .
[12]
Rana A, Rana V, Kumar Sood V, et al. Mutagenic sensitivity, effectiveness and efficiency of gamma rays and ethyl methane sulfonate on soft and semi-hard bread wheat (Triticum aestivum L.) varieties in the north-western Himalayan climate[J]. Int J Radiat Biol, 2024, 100(2): 296-315. DOI: 10.1080/09553002.2023.2261527 .
[13]
Romani PW, Luehring MC, Koerner AM, et al. Characterization and outcomes of profoundly and non-profoundly autistic individuals admitted to a specialized psychiatric inpatient unit[J]. J Autism Dev Disord, 2024. Epub ahead of print. DOI: 10.1007/s10803-024-06640-8 .
[14]
Lukmanji S, Manji SA, Kadhim S, et al. The co-occurrence of epilepsy and autism: a systematic review[J]. Epilepsy Behav, 2019, 98(Pt A): 238-248. DOI: 10.1016/j.yebeh.2019.07.037 .
[15]
Leader G, Abberton C, Cunningham S, et al. Gastrointestinal symptoms in autism spectrum disorder: a systematic review[J]. Nutrients, 2022, 14(7): 1471. PMCID: PMC9003052. DOI: 10.3390/nu14071471 .
[16]
Patel H, Shrimali AL, Mcdougle CJ, et al. Acute medical events in adults with profound autism: a review and illustrative case series[J]. Brain Sci, 2025, 15(7): 740. PMCID: PMC12293176. DOI: 10.3390/brainsci15070740 .
[17]
Sandbank M, Bottema-Beutel K, Crowley S, et al. Project AIM: autism intervention meta-analysis for studies of young children[J]. Psychol Bull, 2020, 146(1): 1-29. PMCID: PMC8783568. DOI: 10.1037/bul0000215 .
[18]
Carr EG, Durand VM. Reducing behavior problems through functional communication training[J]. J Appl Behav Anal, 1985, 18(2): 111-126. PMCID: PMC1307999. DOI: 10.1901/jaba.1985.18-111 .
[19]
Ganz JB, Davis JL, Lund EM, et al. Meta-analysis of PECS with individuals with ASD: investigation of targeted versus non-targeted outcomes, participant characteristics, and implementation phase[J]. Res Dev Disabil, 2012, 33(2): 406-418. DOI: 10.1016/j.ridd.2011.09.023 .
[20]
Flippin M, Reszka S, Watson LR. Effectiveness of the picture exchange communication system (PECS) on communication and speech for children with autism spectrum disorders: a meta-analysis[J]. Am J Speech Lang Pathol, 2010, 19(2): 178-195. DOI: 10.1044/1058-0360(2010/09-0022).
[21]
Jurgens A, Anderson A, Moore DW. Maintenance and generalization of skills acquired through picture exchange communication system (PECS) training: a long-term follow-up[J]. Dev Neurorehabil, 2019, 22(5): 338-347. DOI: 10.1080/17518423.2018.1503619 .
[22]
Choi H, Kim JH, Yang HS, et al. Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment[J]. Mol Autism, 2024, 15(1): 7. PMCID: PMC10807060. DOI: 10.1186/s13229-024-00585-6 .
[23]
Aljead M, Qashta A, Jalal Z, et al. Metabolic and endocrine ADRs of atypical antipsychotics (AAPs) in paediatric patients with autism spectrum disorder (ASD): a review of prevalence, risk factors, and implications for clinical monitoring[J]. J Clin Med, 2025, 14(22): 7942. PMCID: PMC12653775. DOI: 10.3390/jcm14227942 .
[24]
Libowitz MR, Nurmi EL. The burden of antipsychotic-induced weight gain and metabolic syndrome in children[J]. Front Psychiatry, 2021, 12: 623681. PMCID: PMC7994286. DOI: 10.3389/fpsyt.2021.623681 .
[25]
Bartel RL, Knight JR, Worsham W, et al. Discordance between psychiatric diagnoses and medication use in children and adults with autism presenting in crisis[J]. Focus (Am Psychiatr Publ), 2024, 22(2): 150-161. PMCID: PMC11046722. DOI: 10.1176/appi.focus.20230027 .
[26]
Minshawi NF, Hurwitz S, Fodstad JC, et al. The association between self-injurious behaviors and autism spectrum disorders[J]. Psychol Res Behav Manag, 2014, 7: 125-136. PMCID: PMC3990505. DOI: 10.2147/PRBM.S44635 .
[27]
Wachtel L, Luccarelli J, Falligant JM, et al. Electroconvulsive therapy in autism spectrum disorders: an update to the literature[J]. Curr Opin Psychiatry, 2025, 38(2): 79-86. PMCID: PMC12136711. DOI: 10.1097/YCO.0000000000000985 .
[28]
Wachtel LE, Shorter E, Fink M. Electroconvulsive therapy for self-injurious behaviour in autism spectrum disorders: recognizing catatonia is key[J]. Curr Opin Psychiatry, 2018, 31(2): 116-122. DOI: 10.1097/YCO.0000000000000393 .
[29]
Dhossche DM. Decalogue of catatonia in autism spectrum disorders[J]. Front Psychiatry, 2014, 5: 157. PMCID: PMC4222130. DOI: 10.3389/fpsyt.2014.00157 .
[30]
Smith JR, York T, Warn S, et al. Another option for aggression and self-injury, alternative benzodiazepines for catatonia in profound autism[J]. J Child Adolesc Psychopharmacol, 2023, 33(3): 109-117. PMCID: PMC13134536. DOI: 10.1089/cap.2022.0067 .
[31]
Srinivasan A, Luccarelli J, Tamargo R, et al. Treat to sedation: managing intravenous placement for electroconvulsive therapy in autism with intellectual disability and hyperactive catatonia[J]. J Child Adolesc Psychopharmacol, 2025, 35(4): 244-248. PMCID: PMC12408886. DOI: 10.1089/cap.2025.0012 .
[32]
Smith JR, Baldwin I, Termini KA, et al. Use of ECT for children with and without catatonia: a single-site retrospective analysis[J]. J ECT, 2024, 40(3): 154-161. PMCID: PMC11269523. DOI: 10.1097/YCT.0000000000000993 .
[33]
Couse M, Makhinson M, Kelly P. Regulatory and service system challenges in accessing electroconvulsive therapy for catatonia in the presence of autism spectrum disorder[J]. J Am Acad Child Adolesc Psychiatry, 2024, 63(3): 293-295. DOI: 10.1016/j.jaac.2023.09.540 .

脚注

所有作者均声明无利益冲突。


PDF(685 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/